Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX

Autores:
López Puentes, Daniel
Hernández Zambrano, Laura J
Garzón Ospina, Diego
Tipo de recurso:
Article of journal
Fecha de publicación:
2026
Institución:
Universidad Pedagógica y Tecnológica de Colombia
Repositorio:
RiUPTC: Repositorio Institucional UPTC
Idioma:
spa
OAI Identifier:
oai:repositorio.uptc.edu.co:001/18853
Acceso en línea:
https://repositorio.uptc.edu.co/handle/001/18853
https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956
Palabra clave:
Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC.
Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction.
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
id REPOUPTC2_c3528287fe18f13aac6cf99ade42eef2
oai_identifier_str oai:repositorio.uptc.edu.co:001/18853
network_acronym_str REPOUPTC2
network_name_str RiUPTC: Repositorio Institucional UPTC
repository_id_str
dc.title.es-ES.fl_str_mv Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
title Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
spellingShingle Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC.
Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction.
title_short Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
title_full Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
title_fullStr Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
title_full_unstemmed Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
title_sort Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAX
dc.creator.fl_str_mv López Puentes, Daniel
Hernández Zambrano, Laura J
Garzón Ospina, Diego
dc.contributor.author.spa.fl_str_mv López Puentes, Daniel
Hernández Zambrano, Laura J
Garzón Ospina, Diego
dc.subject.none.fl_str_mv Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC.
Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction.
topic Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC.
Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction.
publishDate 2026
dc.date.accessioned.none.fl_str_mv 2026-10-26 10:21:04
dc.date.available.none.fl_str_mv 2026-10-26 10:21:04
dc.date.issued.none.fl_str_mv 2026-10-26
dc.type.spa.fl_str_mv Artículo de revista
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv Journal article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv Text
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 0121-7488
dc.identifier.uri.none.fl_str_mv https://repositorio.uptc.edu.co/handle/001/18853
dc.identifier.doi.none.fl_str_mv 10.19053/uptc.01217488.v16.n2E.2025.19956
dc.identifier.eissn.none.fl_str_mv 2462-7658
dc.identifier.url.none.fl_str_mv https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956
identifier_str_mv 0121-7488
10.19053/uptc.01217488.v16.n2E.2025.19956
2462-7658
url https://repositorio.uptc.edu.co/handle/001/18853
https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.references.spa.fl_str_mv A. R. Tobin, R. Crow, D. V. Urusova, J. C. Klima, N. H. Tolia, and E. Strauch, “Inhibition of a malaria host–pathogen interaction by a computationally designed inhibitor,” Protein Science, vol. 32, no. 1, pp. 1–12, Jan. 2023, doi: 10.1002/pro.4507. [2] R. Moskovitz et al., “Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax,” Nat Commun, vol. 14, no. 1, p. 3637, Jun. 2023, doi: 10.1038/s41467-023-39357-w. [3] M. Yasir et al., “Computational Exploration of Licorice for Lead Compounds against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Molecules, vol. 28, no. 8, p. 3358, Apr. 2023, doi: 10.3390/molecules28083358. [4] M. Yasir et al., “Virtual Screening of Flavonoids against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Curr Comput Aided Drug Des, vol. 20, no. 5, pp. 616–627, Oct. 2024, doi: 10.2174/1573409919666230626140339. [5] M. S. Saddala and P. J. Adi, “Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3),” Heliyon, vol. 4, no. 5, p. e00612, May 2018, doi: 10.1016/j.heliyon.2018.e00612. [6] M. Sivaramakrishnan, K. Kandaswamy, S. Natesan, R. D. Devarajan, S. G. Ramakrishnan, and R. Kothandan, “Molecular docking and dynamics studies on plasmepsin V of malarial parasite Plasmodium vivax,” Inform Med Unlocked, vol. 19, p. 100331, 2020, doi: 10.1016/j.imu.2020.100331. [7] P. Agrawal, H. Singh, H. K. Srivastava, S. Singh, G. Kishore, and G. P. S. Raghava, “Benchmarking of different molecular docking methods for protein-peptide docking,” BMC Bioinformatics, vol. 19, no. S13, p. 426, Feb. 2019, doi: 10.1186/s12859-018-2449-y. [8] R. Ochoa, Á. Santiago, and M. Alegría-Arcos, “Open protocols for docking and MD-based scoring of peptide substrates,” Artificial Intelligence in the Life Sciences, vol. 2, p. 100044, Dec. 2022, doi: 10.1016/j.ailsci.2022.100044. [9] X. Chen et al., “Protenix - Advancing Structure Prediction Through a Comprehensive AlphaFold3 Reproduction,” Jan. 11, 2025. doi: 10.1101/2025.01.08.631967. [10] J. Abramson et al., “Accurate structure prediction of biomolecular interactions with AlphaFold 3,” Nature, vol. 630, no. 8016, pp. 493–500, Jun. 2024, doi: 10.1038/s41586-024-07487-w. [11] A. Biswas, A. Narayan, S. Sinha, and K. Mandal, “Chemically Engineered Peptide Efficiently Blocks Malaria Parasite Entry into Red Blood Cells,” Biochemistry, vol. 64, no. 7, pp. 1501–1508, Apr. 2025, doi: 10.1021/acs.biochem.4c00465. [12] H. Yan, J. Feng, and M. Chen, “Structural Modelling Prediction of Recombinant Plasmodium falciparum K13-F446I and K13-C580Y Gene by AlphaFold Method and Heterologous Expression in Spodoptera frugiperda 9 Cells,” Pathogens, vol. 11, no. 11, Nov. 2022, doi: 10.3390/pathogens11111271. [13] T. H. Dickey and N. H. Tolia, “Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein,” Trends Parasitol, vol. 39, no. 10, pp. 850–858, Oct. 2023, doi: 10.1016/j.pt.2023.06.011. [14] J. D. Batchelor, J. A. Zahm, and N. H. Tolia, “Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC,” Nat Struct Mol Biol, vol. 18, no. 8, pp. 908–914, Aug. 2011, doi: 10.1038/nsmb.2088. [15] J. D. Batchelor, B. M. Malpede, N. S. Omattage, G. T. DeKoster, K. A. Henzler-Wildman, and N. H. Tolia, “Red Blood Cell Invasion by Plasmodium vivax: Structural Basis for DBP Engagement of DARC,” PLoS Pathog, vol. 10, no. 1, Jan. 2014, doi: 10.1371/journal.ppat.1003869. [16] The Plasmodium Genome Database Collaborative, “PlasmoDB: An integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data,” Nucleic Acids Res, vol. 29, no. 1, pp. 66–69, Jan. 2001, doi: 10.1093/nar/29.1.66. [17] A. Bateman et al., “UniProt: the Universal Protein Knowledgebase in 2025,” Nucleic Acids Res, vol. 53, no. D1, pp. D609–D617, Jan. 2025, doi: 10.1093/nar/gkae1010. [18] P. G. Magana Gomez and O. Kovalevskiy, “AlphaFold: A practical guide,” Mar. 06, 2024, Hinxton, UK. doi: 10.6019/TOL.AlphaFold-w.2024.00001.1. [19] Schrodinger LLC, “The PyMOL Molecular Graphics System, Version 3.1.3.1,” 2025. [Online]. Available: https://www.pymol.org/ [20] S. Saha et al., “Molecular mechanism of distinct chemokine engagement and functional divergence of the human Duffy antigen receptor,” Cell, vol. 187, no. 17, pp. 4751-4769.e25, 2024, doi: https://doi.org/10.1016/j.cell.2024.07.005. [21] E. Chen et al., “Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein,” Proceedings of the National Academy of Sciences, vol. 113, no. 22, pp. 6277–6282, 2016, doi: 10.1073/pnas.1600488113. [22] T. A. Rawlinson et al., “Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody,” Nat Microbiol, vol. 4, no. 9, pp. 1497–1507, Sep. 2019, doi: 10.1038/s41564-019-0462-1. [23] L. Sun, T. Fu, D. Zhao, H. Fan, and S. Zhong, “Divide-and-link peptide docking: a fragment-based peptide docking protocol,” Physical Chemistry Chemical Physics, vol. 23, no. 39, pp. 22647–22660, 2021, doi: 10.1039/D1CP02098F. [24] C. L. Gare et al., “Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes,” ChemMedChem, vol. 20, no. 2, Jan. 2025, doi: 10.1002/cmdc.202400637. [25] M. Zalewski, B. Wallner, and S. Kmiecik, “Protein–Peptide Docking with ESMFold Language Model,” J Chem Theory Comput, vol. 21, no. 6, pp. 2817–2821, Mar. 2025, doi: 10.1021/acs.jctc.4c01585.
dc.relation.citationendpage.none.fl_str_mv 22
dc.relation.citationissue.spa.fl_str_mv 2E
dc.relation.citationstartpage.none.fl_str_mv 16
dc.relation.citationvolume.spa.fl_str_mv 16
dc.relation.ispartofjournal.spa.fl_str_mv Ciencia en Desarrollo
dc.relation.bitstream.none.fl_str_mv https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/download/19956/16068
dc.relation.citationedition.spa.fl_str_mv Núm. 2E , Año 2025 : II Jornada de Investigación en Ciencias Biomédicas
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Universidad Pedagógica y Tecnológica de Colombia
dc.source.spa.fl_str_mv https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/19956
institution Universidad Pedagógica y Tecnológica de Colombia
bitstream.url.fl_str_mv https://repositorio.uptc.edu.co/bitstreams/fbacff53-fa68-4a41-90f8-dff8d3b97621/download
bitstream.checksum.fl_str_mv cbe09367425cda257d14411777360f82
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Institucional UPTC
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1881673976688672768
spelling López Puentes, DanielHernández Zambrano, Laura JGarzón Ospina, Diego2026-10-26 10:21:042026-10-26 10:21:042026-10-260121-7488https://repositorio.uptc.edu.co/handle/001/1885310.19053/uptc.01217488.v16.n2E.2025.199562462-7658https://doi.org/10.19053/uptc.01217488.v16.n2E.2025.19956application/pdfspaUniversidad Pedagógica y Tecnológica de Colombiahttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.esinfo:eu-repo/semantics/openAccessEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.http://purl.org/coar/access_right/c_abf2https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/19956Plasmodium vivax, inhibidor de péptidos, interacción DBP-DARC.Plasmodium vivax, Peptide inhibitor, DBP-DARC interaction.Diseño de un péptido inhibidor de la interacción DBP-DARC En Plasmodium VIVAXArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleJournal articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a85A. R. Tobin, R. Crow, D. V. Urusova, J. C. Klima, N. H. Tolia, and E. Strauch, “Inhibition of a malaria host–pathogen interaction by a computationally designed inhibitor,” Protein Science, vol. 32, no. 1, pp. 1–12, Jan. 2023, doi: 10.1002/pro.4507. [2] R. Moskovitz et al., “Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax,” Nat Commun, vol. 14, no. 1, p. 3637, Jun. 2023, doi: 10.1038/s41467-023-39357-w. [3] M. Yasir et al., “Computational Exploration of Licorice for Lead Compounds against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Molecules, vol. 28, no. 8, p. 3358, Apr. 2023, doi: 10.3390/molecules28083358. [4] M. Yasir et al., “Virtual Screening of Flavonoids against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation,” Curr Comput Aided Drug Des, vol. 20, no. 5, pp. 616–627, Oct. 2024, doi: 10.2174/1573409919666230626140339. [5] M. S. Saddala and P. J. Adi, “Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3),” Heliyon, vol. 4, no. 5, p. e00612, May 2018, doi: 10.1016/j.heliyon.2018.e00612. [6] M. Sivaramakrishnan, K. Kandaswamy, S. Natesan, R. D. Devarajan, S. G. Ramakrishnan, and R. Kothandan, “Molecular docking and dynamics studies on plasmepsin V of malarial parasite Plasmodium vivax,” Inform Med Unlocked, vol. 19, p. 100331, 2020, doi: 10.1016/j.imu.2020.100331. [7] P. Agrawal, H. Singh, H. K. Srivastava, S. Singh, G. Kishore, and G. P. S. Raghava, “Benchmarking of different molecular docking methods for protein-peptide docking,” BMC Bioinformatics, vol. 19, no. S13, p. 426, Feb. 2019, doi: 10.1186/s12859-018-2449-y. [8] R. Ochoa, Á. Santiago, and M. Alegría-Arcos, “Open protocols for docking and MD-based scoring of peptide substrates,” Artificial Intelligence in the Life Sciences, vol. 2, p. 100044, Dec. 2022, doi: 10.1016/j.ailsci.2022.100044. [9] X. Chen et al., “Protenix - Advancing Structure Prediction Through a Comprehensive AlphaFold3 Reproduction,” Jan. 11, 2025. doi: 10.1101/2025.01.08.631967. [10] J. Abramson et al., “Accurate structure prediction of biomolecular interactions with AlphaFold 3,” Nature, vol. 630, no. 8016, pp. 493–500, Jun. 2024, doi: 10.1038/s41586-024-07487-w. [11] A. Biswas, A. Narayan, S. Sinha, and K. Mandal, “Chemically Engineered Peptide Efficiently Blocks Malaria Parasite Entry into Red Blood Cells,” Biochemistry, vol. 64, no. 7, pp. 1501–1508, Apr. 2025, doi: 10.1021/acs.biochem.4c00465. [12] H. Yan, J. Feng, and M. Chen, “Structural Modelling Prediction of Recombinant Plasmodium falciparum K13-F446I and K13-C580Y Gene by AlphaFold Method and Heterologous Expression in Spodoptera frugiperda 9 Cells,” Pathogens, vol. 11, no. 11, Nov. 2022, doi: 10.3390/pathogens11111271. [13] T. H. Dickey and N. H. Tolia, “Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein,” Trends Parasitol, vol. 39, no. 10, pp. 850–858, Oct. 2023, doi: 10.1016/j.pt.2023.06.011. [14] J. D. Batchelor, J. A. Zahm, and N. H. Tolia, “Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC,” Nat Struct Mol Biol, vol. 18, no. 8, pp. 908–914, Aug. 2011, doi: 10.1038/nsmb.2088. [15] J. D. Batchelor, B. M. Malpede, N. S. Omattage, G. T. DeKoster, K. A. Henzler-Wildman, and N. H. Tolia, “Red Blood Cell Invasion by Plasmodium vivax: Structural Basis for DBP Engagement of DARC,” PLoS Pathog, vol. 10, no. 1, Jan. 2014, doi: 10.1371/journal.ppat.1003869. [16] The Plasmodium Genome Database Collaborative, “PlasmoDB: An integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data,” Nucleic Acids Res, vol. 29, no. 1, pp. 66–69, Jan. 2001, doi: 10.1093/nar/29.1.66. [17] A. Bateman et al., “UniProt: the Universal Protein Knowledgebase in 2025,” Nucleic Acids Res, vol. 53, no. D1, pp. D609–D617, Jan. 2025, doi: 10.1093/nar/gkae1010. [18] P. G. Magana Gomez and O. Kovalevskiy, “AlphaFold: A practical guide,” Mar. 06, 2024, Hinxton, UK. doi: 10.6019/TOL.AlphaFold-w.2024.00001.1. [19] Schrodinger LLC, “The PyMOL Molecular Graphics System, Version 3.1.3.1,” 2025. [Online]. Available: https://www.pymol.org/ [20] S. Saha et al., “Molecular mechanism of distinct chemokine engagement and functional divergence of the human Duffy antigen receptor,” Cell, vol. 187, no. 17, pp. 4751-4769.e25, 2024, doi: https://doi.org/10.1016/j.cell.2024.07.005. [21] E. Chen et al., “Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein,” Proceedings of the National Academy of Sciences, vol. 113, no. 22, pp. 6277–6282, 2016, doi: 10.1073/pnas.1600488113. [22] T. A. Rawlinson et al., “Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody,” Nat Microbiol, vol. 4, no. 9, pp. 1497–1507, Sep. 2019, doi: 10.1038/s41564-019-0462-1. [23] L. Sun, T. Fu, D. Zhao, H. Fan, and S. Zhong, “Divide-and-link peptide docking: a fragment-based peptide docking protocol,” Physical Chemistry Chemical Physics, vol. 23, no. 39, pp. 22647–22660, 2021, doi: 10.1039/D1CP02098F. [24] C. L. Gare et al., “Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes,” ChemMedChem, vol. 20, no. 2, Jan. 2025, doi: 10.1002/cmdc.202400637. [25] M. Zalewski, B. Wallner, and S. Kmiecik, “Protein–Peptide Docking with ESMFold Language Model,” J Chem Theory Comput, vol. 21, no. 6, pp. 2817–2821, Mar. 2025, doi: 10.1021/acs.jctc.4c01585.222E1616Ciencia en Desarrollohttps://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/download/19956/16068Núm. 2E , Año 2025 : II Jornada de Investigación en Ciencias BiomédicasPublicationOREORE.xmltext/xml2715https://repositorio.uptc.edu.co/bitstreams/fbacff53-fa68-4a41-90f8-dff8d3b97621/downloadcbe09367425cda257d14411777360f82MD51falseAnonymousREAD001/18853oai:repositorio.uptc.edu.co:001/188532026-10-30 07:03:15.924https://creativecommons.org/licenses/by-nc-nd/4.0/deed.esmetadata.onlyhttps://repositorio.uptc.edu.coRepositorio Institucional UPTCbdigital@metabiblioteca.com